4//SEC Filing
Dorenbaum Alejandro 4
Accession 0001209191-22-061032
CIK 0001637715other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 6:07 PM ET
Size
10.2 KB
Accession
0001209191-22-061032
Insider Transaction Report
Form 4
Dorenbaum Alejandro
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2022-12-09+125,000→ 125,000 totalExercise: $1.80Exp: 2032-12-08→ Common Stock (125,000 underlying) - Gift
Common Stock
2022-08-12−22,348→ 30,000 total
Footnotes (1)
- [F1]The shares vest in a series of 16 successive equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001606083
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 6:07 PM ET
- Size
- 10.2 KB